Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on September 21, 2009

Circulation. 2009
Published online before print September 21, 2009, doi: 10.1161/CIRCULATIONAHA.109.854299
A more recent version of this article appeared on October 6, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
120/14/1364    most recent
CIRCULATIONAHA.109.854299v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Spyridopoulos, I.
Right arrow Articles by Dimmeler, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spyridopoulos, I.
Right arrow Articles by Dimmeler, S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Cytomegalovirus Infections
Related Collections
Right arrow Pathophysiology
Right arrow Chronic ischemic heart disease
Right arrow Genetics of cardiovascular disease
Right arrowRelated Article

Submitted on January 28, 2009
Accepted on July 28, 2009

Accelerated Telomere Shortening in Leukocyte Subpopulations of Patients With Coronary Heart Disease. Role of Cytomegalovirus Seropositivity

Ioakim Spyridopoulos MD*, Jedrzej Hoffmann MD, Alexandra Aicher MD, Tim H. Brümmendorf MD, Hans W. Doerr MD, Andreas M. Zeiher MD, and Stefanie Dimmeler PhD

From the Departments of Cardiology and Institute for Cardiovascular Regeneration, Centre of Molecular Medicine (I.S., J.H., A.A., A.M.Z., S.D.) and Institute of Medical Virology (H.W.D.), Johann Wolfgang Goethe University of Frankfurt, Frankfurt, Germany; Department of Oncology and Hematology (T.H.B.), University Cancer Center Hamburg-Eppendorf, Hamburg, Germany; Department of Hematology and Oncology (T.H.B.), University Hospital Aachen, Aachen, Germany; and Institute of Human Genetics (I.S.), Newcastle University, Newcastle Upon Tyne, United Kingdom.

* To whom correspondence should be addressed. E-mail: ioakim.spyridopoulos{at}newcastle.ac.uk.

Background—Shortening of mean telomere length (TL) in white blood cells is correlated with the development of coronary heart disease (CHD) and with increased mortality due to infectious disease. The goal of the present study was to investigate whether telomere shortening in CHD is restricted to specific peripheral blood lymphocyte and/or myeloid cell subpopulations. Results were correlated to TL in CD34+ hematopoietic peripheral blood stem cells and progenitor cells obtained from the same individual patients.

Methods and Results—TL was measured by multicolor flow cytometry–fluorescent in situ hybridization in 12 leukocyte subpopulations after immunomagnetic bead sorting. We investigated TL in 14 young (mean age 25 years) and 13 older (mean age 65 years) healthy male volunteers and in 25 age-matched patients with CHD (mean age 65 years). We show that TL in granulocytes and monocytes mirrors TL of CD34+ peripheral blood stem cells and progenitor cells extremely well (r=0.95, P<0.0001) in patients and in healthy adults. TL was {approx}0.5 kilobases (kb) shorter in leukocytes from patients with CHD than in their age-matched control subjects. This difference was identical for CD34+ peripheral blood stem cells and progenitor cells, monocytes, granulocytes, B lymphocytes, and CD4+ T cells, including their memory and naïve subpopulations. Surprisingly, only in cytotoxic CD8+ T lymphocytes, we found a substantially increased TL deficit of 1.0 kb in CHD patients as opposed to control subjects. Further analysis revealed that TL shortening was particularly pronounced in CD8+CD28- T cells obtained from cytomegalovirus-seropositive CHD patients, whereas such a difference was not observed in healthy cytomegalovirus-positive as opposed to cytomegalovirus-negative control subjects. Finally, TL shortening of CD8+CD45RA+ T cells was correlated with the decrease in left ventricular function in CHD patients (r=0.629, P=0.001).

Conclusions—Telomere shortening in patients with CHD could potentially be attributed to either inherited TL shortening or acquired accelerated telomere shortening restricted to the hematopoietic system, which affects the baseline TL of all peripheral blood cell populations, including peripheral blood stem cells and progenitor cells. In addition, cytomegalovirus-seropositive patients but not healthy control subjects exhibited further shortening of their cytotoxic T lymphocytes. Surprisingly, TL shortening of CD8+ T lymphocytes in CHD patients demonstrated a very strong correlation with cardiac dysfunction, which suggests a mechanistic link between CHD and immunosenescence.


Key words: telomere • coronary disease • cytomegalovirus • aging • immunology • stem cells • T cells


Related Article:

Clinical Summaries
Circulation 2009 120: 1337-1338. [Extract] [Full Text]